Sch B Enhances the Sensitivity of Glioma to Temozolomide by Inducing Lethal Autophagy by Regulating the KCNB1/AMPK/mTOR Axis

Schisandrin B (Sch B) is an active lignan derived from the Chinese herb Schisandra chinensis and exhibits multi-target anti-tumor activity. However, the mechanism and effect of Sch B in reversing temozolomide (TMZ) resistance in glioblastoma (GBM) remain unclear. In this study, through transcriptome screening, it was found that KCNB1 (Kv2.1) is the only common differentially expressed gene regulated by Sch B and TMZ alone or in combination. Database analysis revealed that its expression is downregulated in GBM and is closely related to poor prognosis and TMZ resistance in patients. In the TMZ-resistant cell line induced by U87, KCNB1 also shows a low expression level. The results of in vitro experiments indicated that the combined treatment of Sch B and TMZ can significantly upregulate KCNB1 and Kv2.1 expression and thereby regulate the AMPK/mTOR signaling axis (increased p-AMPK level and decreased p-mTOR level), induce lethal autophagy (increased LC3B-II/I ratio and increased p62 degradation), inhibit the proliferation of resistant cells, promote apoptosis, and restore TMZ sensitivity. Knockdown of KCNB1, the use of a Kv2.1-specific inhibitor, or the AMPK inhibitor Compound C can partially reverse these effects. The in vivo nude mouse xenograft tumor model further confirmed that the combined treatment can significantly inhibit tumor growth, upregulate the expression of KCNB1 in tumor tissues, activate the AMPK/mTOR pathway, and enhance autophagy levels. In summary, this study first reveals that Sch B upregulates KCNB1 to activate the AMPK/mTOR pathway and induces lethal autophagy, thereby reversing TMZ resistance in GBM, providing experimental evidence for the clinical application of Sch B as a TMZ sensitizer.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-16
DOI
https://doi.org/10.3390/cimb48111237
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sch B Enhances the Sensitivity of Glioma to Temozolomide by Inducing Lethal Autophagy by Regulating the KCNB1/AMPK/mTOR Axis

Na Wen, Zebo Tang, Jianxin Liu, Lei Liu et al.
1 links
Current Issues in Molecular Biology
Glioma Diagnosis and Treatment
article

Sch B Enhances the Sensitivity of Glioma to Temozolomide by Inducing Lethal Autophagy by Regulating the KCNB1/AMPK/mTOR Axis

Na Wen, Zebo Tang, Jianxin Liu, Lei Liu, Moli Yin, Shifei Gong
article en

Abstract

Schisandrin B (Sch B) is an active lignan derived from the Chinese herb Schisandra chinensis and exhibits multi-target anti-tumor activity. However, the mechanism and effect of Sch B in reversing temozolomide (TMZ) resistance in glioblastoma (GBM) remain unclear. In this study, through transcriptome screening, it was found that KCNB1 (Kv2.1) is the only common differentially expressed gene regulated by Sch B and TMZ alone or in combination. Database analysis revealed that its expression is downregulated in GBM and is closely related to poor prognosis and TMZ resistance in patients. In the TMZ-resistant cell line induced by U87, KCNB1 also shows a low expression level. The results of in vitro experiments indicated that the combined treatment of Sch B and TMZ can significantly upregulate KCNB1 and Kv2.1 expression and thereby regulate the AMPK/mTOR signaling axis (increased p-AMPK level and decreased p-mTOR level), induce lethal autophagy (increased LC3B-II/I ratio and increased p62 degradation), inhibit the proliferation of resistant cells, promote apoptosis, and restore TMZ sensitivity. Knockdown of KCNB1, the use of a Kv2.1-specific inhibitor, or the AMPK inhibitor Compound C can partially reverse these effects. The in vivo nude mouse xenograft tumor model further confirmed that the combined treatment can significantly inhibit tumor growth, upregulate the expression of KCNB1 in tumor tissues, activate the AMPK/mTOR pathway, and enhance autophagy levels. In summary, this study first reveals that Sch B upregulates KCNB1 to activate the AMPK/mTOR pathway and induces lethal autophagy, thereby reversing TMZ resistance in GBM, providing experimental evidence for the clinical application of Sch B as a TMZ sensitizer.

Current Issues in Molecular BiologyVol. 48(11)
Jilin Medical University (CN), Xi'an Jiaotong University (CN)
Jilin Province Development and Reform Commission, Education Department of Jilin Province
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon